The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. This conference covers commercialization hurdles facing the cell and gene therapy sector as well as a wide range of topics from clinical trial design, alternative payment models, scale-up and supply chain platforms for advanced therapies. 

Featured agenda item

Alternative IPO Strategies for Cell and Gene Therapy Companies
This event took place on Monday, October 12, 2020 
Cooley partner Yvan-Claude Pierre was a featured speaker.

On October 12th, 2020, Cooley partner Yvan-Claude Pierre participated in a panel discussing the uptick of biotech-focused firms in the SPAC space, what cell and gene therapy companies need to know about this alternative to a traditional IPO if approached, and what seasoned executives of public companies should know about potentially sponsoring their own biotech focused SPAC.

No recording available

Posted by